The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation
Abstract
Background Currently available antiarrhythmic drugs have limited efficacy for acute termination of atrial fibrillation and flutter, especially if the arrhythmia is not of recent onset. The purpose of this multicenter study was to determine the efficacy and safety of repeated doses of intravenous ibutilide, a class III antiarrhythmic drug, in terminating atrial fibrillation or flutter. Methods and Results Two hundred sixty-six patients with sustained atrial fibrillation (n=133) or flutter (n=133), with an arrhythmia duration of 3 hours to 45 days, were randomized to receive up to two 10-minute infusions, separated by 10 minutes, of ibutilide (1.0 and 0.5 mg or 1.0 and 1.0 mg) or placebo. The conversion rate was 47% after ibutilide and 2% after placebo (P<.0001). The two ibutilide dosing regimens did not differ in conversion efficacy (44% versus 49%). Efficacy was higher in atrial flutter than fibrillation (63% versus 31%,P<.0001). In atrial fibrillation but not flutter, conversion rates were higher in patients with a shorter arrhythmia duration or a normal left atrial size. Arrhythmia termination occurred a mean of 27 minutes after start of the infusion. Of 180 ibutilide-treated patients, 15 (8.3%) developed polymorphic ventricular tachycardia during or soon after the infusion. The arrhythmia required cardioversion in 3 patients (1.7%) and was nonsustained in 12 patients (6.7%). Conclusions Intravenous ibutilide given in repeated doses is effective in rapidly terminating atrial fibrillation and flutter and under monitored conditions is an alternative to current cardioversion options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial Fibrillation Begets Atrial Fibrillation: A Study in Awake Chronically Instrumented Goats
Wijffels, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,494
Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study.
Sanfilippo, A. J., Abascal, V. M., Sheehan, M., Oertel, L. B., Harrigan, P., Hughes, R. A., & Weyman, A. E. (1990) · Circulation · doi:10.1161/01.cir.82.3.792 · Cited by 739
Rensma, P. L., Allessie, M. A., Lammers, W. J., Bonke, F. I., & Schalij, M. J. (1988) · Circulation Research · doi:10.1161/01.res.62.2.395 · Cited by 640
Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 488
Kowey, P. R., Levine, J. H., Herre, J. M., Pacifico, A., Lindsay, B. D., Plumb, V. J., Janosik, D. L., Kopelman, H. A., & Scheinman, M. M. (1995) · Circulation · doi:10.1161/01.cir.92.11.3255 · Cited by 298
Suttorp, M. J., Kingma, J. H., Jessurun, E. R., Lie-A-Huen, L., Van Hemel, N. M., & Lie, K. I. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90326-k · Cited by 282
Scheinman, M. M., Levine, J. H., Cannom, D. S., Friehling, T. D., Kopelman, H. A., Chilson, D. A., Platia, E. V., Wilber, D. J., & Kowey, P. R. (1995) · Circulation · doi:10.1161/01.cir.92.11.3264 · Cited by 257
Atrial enlargement as a consequence of atrial fibrillation.
Zatuchni, J. (1991) · Circulation · doi:10.1161/circ.83.4.1826477 · Cited by 230
Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation.
Wang, Z., Pagé, P., & Nattel, S. (1992) · Circulation Research · doi:10.1161/01.res.71.2.271 · Cited by 224
Wang, J., Bourne, G. W., Wang, Z., Villemaire, C., Talajic, M., & Nattel, S. (1993) · Circulation · doi:10.1161/01.cir.88.3.1030 · Cited by 209
Hohnloser, S. H., van de Loo, A., & Baedeker, F. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00286-5 · Cited by 204
Yang, T., Snyders, D. J., & Roden, D. M. (1995) · Circulation · doi:10.1161/01.cir.91.6.1799 · Cited by 192
Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm
Borgeat, A., Goy, J.-J., Maendly, R., Kaufmann, U., Grbic, M., & Sigwart, U. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90022-6 · Cited by 191
Falk, R. H. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-2-107 · Cited by 183
Suttorp, M. J., Kingma, J. H., Lie-A-Huen, L., & Mast, E. G. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90253-1 · Cited by 176
Intravenous flecainide versus Amiedarone fof recent-onset atrial fibrillation
Donovan, K. D., Power, B. M., Hockings, B. E. F., Dobb, G. J., & Lee, K.-Y. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80655-9 · Cited by 168
Lee, K. S. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10779-9 · Cited by 157
Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion
Fenster, P. E., Comess, K. A., Marsh, R., Katzenberg, C., & Hager, W. D. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90692-0 · Cited by 154
Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs
Feld, G. K., Chen, P., NICOD, P. H., FLECK, R. P., & Meyer, D. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90856-v · Cited by 147
Manning, W. J., Silverman, D. I., Katz, S. E., Riley, M. F., Doherty, R. M., Munson, J. T., & Douglas, P. S. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80632-8 · Cited by 128
Comparison of flecainide and procainamide in cardioversion of atrial fibrillation
Madrid, A. H., Moro, C., Marín-Huerta, E., Mestre, J. L., Novo, L., & COSTA, A. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.8.1127 · Cited by 124
Bianconi, L., BOCCADAMO, R., Pappalardo, A., Gentili, C., & Pistolese, M. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90530-4 · Cited by 123
Sung, R. J., Tan, H. L., Karagounis, L. A., HANYOK, J. J., Falk, R. H., Platia, E. V., Das, G., & Hardy, S. A. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90324-0 · Cited by 121
Halpern, S. W., Ellrodt, G. A., Singh, B. N., & Mandel, W. J. (1980) · Heart · doi:10.1136/hrt.44.5.589 · Cited by 106
Torsades de pointes and proarrhythmia
Ben-David, J., & Zipes, D. P. (1993) · The Lancet · doi:10.1016/0140-6736(93)90708-o · Cited by 95
Faniel, R. A., & Schoenfeld, P. L. (1983) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a061437 · Cited by 93
Boahene, K. A., Klein, G. J., Yee, R. K., Sharma, A. D., & Fujimura, O. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90384-2 · Cited by 87
Feld, G. K., Venkatesh, N., & Singh, B. N. (1986) · Circulation · doi:10.1161/01.cir.74.1.197 · Cited by 86
Strasberg, B., Arditti, A., Sclarovsky, S., Lewin, R. F., Buimovici, B., & Agmon, J. (1985) · International Journal of Cardiology · doi:10.1016/0167-5273(85)90172-x · Cited by 65
Olshansky, B., Okumura, K., Hess, P. G., Henthorn, R. W., & Waldo, A. L. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90102-7 · Cited by 57
Atrial Flutter—Update on the Mechanism and Treatment
Olshansky, B., Wilber, D. J., & Hariman, R. J. (1992) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1992.tb04174.x · Cited by 55
Efficacy of intravenous propafenone for the acute management of atrial fibrillation
Vita, J. A., Friedman, P. L., Cantillon, C. O., & Antman, E. M. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90191-4 · Cited by 53
Lee, K. S., Tsai, T. D., & Lee, E. W. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90704-l · Cited by 53
Use of composite endpoints in thrombolysis trials of acute myocardial infarction
D, E. B. M., Cannon, C. P., & McCabe, C. H. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90101-h · Cited by 46
Buchanan, L. V., Turcotte, U. M., Kabell, G., & Gibson, J. K. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199307000-00002 · Cited by 41
Cimini, M. G., Brunden, M. N., & Gibson, J. K. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90467-i · Cited by 40
Intravenous flecainide acetate for supraventricular tachycardias
Hellestrand, K. J. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90496-1 · Cited by 38
Activation Mapping of Reentry Around an Anatomical Barrier in the Canine Atrium:
Boyden, P. A., & Graziano, J. N. (1993) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1993.tb01230.x · Cited by 31
Nabih, M., Prcevski, P., Fromm, B. S., Lavine, S. J., Elnabtity, M., MUNIR, A., Steinman, R. T., Meissner, M. D., & Lehmann, M. H. (1993) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1993.tb00991.x · Cited by 31
Acute Intravenous Conversion of Canine Atrial Flutter
Buchanan, L. V., Kabell, G., & Gibson, J. K. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199504000-00005 · Cited by 21
Feld, G. K., Venkatesh, N., & Singh, B. N. (1988) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198805000-00010 · Cited by 19
Cited by
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Metadata
- Authors
- Stambler, B. S., Wood, M. A., Ellenbogen, K. A., Perry, K. T., Wakefield, L. K., & VanderLugt, J. T.
- Venue
- Circulation
- Published
- 1996-10
- Volume
- 94
- Issue
- 7
- Pages
- 1613-1621
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1966064887
- Cited by
- 486
- References
- 42
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.